Short Link N Modulates Inflammasome Activity in Intervertebral Discs Through Interaction with CD14

Area of Science:

• Biochemistry
• Immunology
• Pain Research

Background:

• Intervertebral disc degeneration and pain are linked to NLRP3 inflammasome activation and IL-1β processing.
• Toll-like receptor stimulation and CD14 are crucial for inflammasome activation.

Purpose of the Study:

• To investigate if the peptide sLN modulates IL-1β and inflammasome activity via interaction with CD14.
• To elucidate the mechanism of sLN's anti-inflammatory and analgesic effects in disc tissues.

Main Methods:

• Disc cells were treated with LPS with or without sLN to analyze Caspase-1, IL-1β, and NFκB.
• Peptide docking and immunoprecipitation were used to confirm sLN and CD14 interaction.

Main Results:

• sLN inhibited LPS-induced NFκB and Caspase-1 activation, reducing IL-1β maturation and secretion.
• A significant decrease in inflammasome markers was observed with sLN treatment.
• Direct interaction between sLN and the CD14 LPS-binding pocket was confirmed.

Conclusions:

• sLN mitigates IL-1β and inflammasome activity in disc cells.
• sLN shows potential as a therapeutic agent for discogenic pain by targeting CD14-mediated inflammasome pathways.